Cargando…

Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with limited treatment options. Although activating mutations of the KRAS GTPase are the predominant dependency present in >90% of PDAC patients, targeting KRAS mutants directly has been challenging in PDAC. Similarly, strategies targ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Derek K., Oni, Tobiloba E., Thalappillil, Jennifer S., Park, Youngkyu, Ting, Hsiu-Chi, Alagesan, Brinda, Prasad, Nadia V., Addison, Kenneth, Rivera, Keith D., Pappin, Darryl J., Van Aelst, Linda, Tuveson, David A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2021
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166058/ https://www.ncbi.nlm.nih.gov/pubmed/34021083 http://dx.doi.org/10.1073/pnas.2016904118

Ejemplares similares

rSK1 in Rat Neurons: A Controller of Membrane rSK2?
por: Autuori, Eleonora, et al.
Publicado: (2019)

Ras-activated RSK1 phosphorylates EBP50 to regulate its nuclear localization and promote cell proliferation
por: Lim, HooiCheng, et al.
Publicado: (2016)

RSK1 and RSK2 serine/threonine kinases regulate different transcription programs in cancer
por: Yang, Won Seok, et al.
Publicado: (2023)

Recruitment and Activation of RSK2 by HIV-1 Tat
por: Hetzer, Claudia, et al.
Publicado: (2007)

RSK1 activation promotes invasion in nodular melanoma
por: Salhi, Amel, et al.
Publicado: (2015)

RSK1 SUMOylation is required for KSHV lytic replication
por: Liu, Zhenshan, et al.
Publicado: (2021)

ERK1/2-RSK regulation of oestrogen homeostasis
por: Wright, Eric B., et al.
Publicado: (2023)

A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers
por: Cheng, Rongjie, et al.
Publicado: (2022)

The Role of Wild-Type RAS in Oncogenic RAS Transformation
por: Sheffels, Erin, et al.
Publicado: (2021)

SOAT1 promotes mevalonate pathway dependency in pancreatic cancer
por: Oni, Tobiloba E., et al.
Publicado: (2020)

Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction
por: Ito, Reina E., et al.
Publicado: (2021)

Oncogenic KRAS signalling in pancreatic cancer
por: Eser, S, et al.
Publicado: (2014)

Oncogenic KRAS: Signaling and Drug Resistance
por: Kim, Hyeon Jin, et al.
Publicado: (2021)

Pan-KRAS inhibitor disables oncogenic signalling and tumour growth
por: Kim, Dongsung, et al.
Publicado: (2023)

KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation
por: Tran, Timothy H., et al.
Publicado: (2021)

Involvement of RSK1 activation in malformin-enhanced cellular fibrinolytic activity
por: Koizumi, Yukio, et al.
Publicado: (2018)

Transforming ras oncogenes and multistage carcinogenesis.
por: Balmain, A.
Publicado: (1985)

Ras oncogene mutation in multiple myeloma
Publicado: (1989)

RAS: Striking at the Core of the Oncogenic Circuitry
por: Gimple, Ryan C., et al.
Publicado: (2019)

RSK Isoforms in Acute Myeloid Leukemia
por: Youn, Minyoung, et al.
Publicado: (2021)

Graded inhibition of oncogenic Ras-signaling by multivalent Ras-binding domains
por: Augsten, Martin, et al.
Publicado: (2014)

Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation()()
por: Drosos, Yiannis, et al.
Publicado: (2016)

Loss of Jag1 cooperates with oncogenic Kras to induce pancreatic cystic neoplasms
por: Chung, Wen-Cheng, et al.
Publicado: (2020)

Stat1 Phosphorylation Determines Ras Oncogenicity by Regulating p27(Kip1)
por: Wang, Shuo, et al.
Publicado: (2008)

Immune modulatory effects of oncogenic KRAS in cancer
por: Hamarsheh, Shaima’a, et al.
Publicado: (2020)

Targeting the undruggable oncogenic KRAS: the dawn of hope
por: Asimgil, Hande, et al.
Publicado: (2022)

Conquering oncogenic KRAS and its bypass mechanisms
por: Hou, Pingping, et al.
Publicado: (2022)

Akt-mediated Ephexin1–Ras interaction promotes oncogenic Ras signaling and colorectal and lung cancer cell proliferation
por: Kim, Jeeho, et al.
Publicado: (2021)

The ribosomal S6 kinase 2 (RSK2)–SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signaling
por: Lopez, Jocelyne, et al.
Publicado: (2023)

Impact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation
por: Toulany, Mahmoud, et al.
Publicado: (2011)

SCD1 Expression Is Dispensable for Hepatocarcinogenesis Induced by AKT and Ras Oncogenes in Mice
por: Li, Lei, et al.
Publicado: (2013)

Oncogenic RAS-induced CK1α drives nuclear FOXO proteolysis
por: Zhang, F, et al.
Publicado: (2018)

The PDK1–Rsk Signaling Pathway Controls Langerhans Cell Proliferation and Patterning
por: Zaru, Rossana, et al.
Publicado: (2015)

Aberrant expression of RSK1 characterizes high‐grade gliomas with immune infiltration
por: M. Hajj, Glaucia N., et al.
Publicado: (2019)

The functional regulatory details of ERK2 in complex with RSK1: an in silico insight
por: Jafari, Sepideh, et al.
Publicado: (2021)

Phosphorylation of REPS1 at Ser709 by RSK attenuates the recycling of transferrin receptor
por: Kim, Seong Heon, et al.
Publicado: (2021)

Marine-Based Candidates as Potential RSK1 Inhibitors: A Computational Study
por: AlTarabeen, Mousa, et al.
Publicado: (2022)

RSK1 vs. RSK2 Inhibitory Activity of the Marine β-Carboline Alkaloid Manzamine A: A Biochemical, Cervical Cancer Protein Expression, and Computational Study
por: Mayer, Alejandro M. S., et al.
Publicado: (2021)

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
por: Barbie, David A., et al.
Publicado: (2009)

Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis
por: Zheng, Kang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4ua7b3j2hqph7f58kpcmcp9vvt